Published in Exp Hematol on July 27, 2017
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 14.28
Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 13.50
Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science (1996) 12.54
Genome-scale CRISPR-Cas9 knockout screening in human cells. Science (2013) 12.36
Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell (2008) 11.53
CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol (2014) 9.18
Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science (2010) 5.50
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell (2014) 5.43
In vivo genome editing using Staphylococcus aureus Cas9. Nature (2015) 5.26
Production and characterization of adeno-associated viral vectors. Nat Protoc (2006) 4.11
A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell (2010) 2.95
Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell (2014) 2.55
Genetic knockouts and knockins in human somatic cells. Nat Protoc (2007) 2.21
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature (2015) 2.15
Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks. Mol Cell Biol (2003) 2.01
Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res (2014) 1.96
CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat Methods (2015) 1.88
Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature (2015) 1.82
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol (2015) 1.71
AAV-mediated gene targeting methods for human cells. Nat Protoc (2011) 1.70
Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science (2014) 1.56
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Nat Biotechnol (2014) 1.43
Hematopoietic stem cells: concepts, definitions, and the new reality. Blood (2015) 1.30
Quantifying on- and off-target genome editing. Trends Biotechnol (2015) 1.15
Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications. Genome Biol (2015) 1.10
In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc (2008) 1.09
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions. Cancer Discov (2016) 1.08
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. Cancer Discov (2016) 1.08
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature (2016) 1.06
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol (2016) 1.06
Inflammation-Induced Emergency Megakaryopoiesis Driven by Hematopoietic Stem Cell-like Megakaryocyte Progenitors. Cell Stem Cell (2015) 1.03
Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine. Cell (2016) 1.01
Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol (2016) 0.98
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia. Cell Rep (2016) 0.94
Genome engineering: the next genomic revolution. Nat Methods (2014) 0.94
Analyzing CRISPR genome-editing experiments with CRISPResso. Nat Biotechnol (2016) 0.92
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells. Sci Transl Med (2016) 0.92
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9. Cell Rep (2016) 0.91
CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering. Nucleic Acids Res (2016) 0.90
Hematopoietic stem cells: potential new applications for translational medicine. J Stem Cells (2014) 0.90
Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci. Nat Genet (2017) 0.78
Genome editing via delivery of Cas9 ribonucleoprotein. Methods (2017) 0.76